PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia. - Gordon BK; Muhowski EM; Singh J; Ravikrishnan J; Peris-Cuesta A; Diaz Rohena D; Sanchez JR; Thangavadivel S; Benrashid S; He A; Marr AR; Mitchell AD; et al. (Blood cancer discovery, 2026)